Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 4 |
2023 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders.
Commun Med (Lond). 2022 Jul 11;2:85. doi: 10.1038/s43856-022-00151-2. eCollection 2022.
Commun Med (Lond). 2022.
PMID: 35832309
Free PMC article.
Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses.
Roeder AJ, Koehler MA, Jasbi P, McKechnie D, Vanderhoof J, Edwards BA, Gonzalez-Moa MJ, Seit-Nebi A, Svarovsky SA, Lake DF.
Roeder AJ, et al.
Vaccines (Basel). 2022 Sep 3;10(9):1459. doi: 10.3390/vaccines10091459.
Vaccines (Basel). 2022.
PMID: 36146537
Free PMC article.
Item in Clipboard
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2.
Lake DF, Roeder AJ, Kaleta E, Jasbi P, Pfeffer K, Koelbela C, Periasamy S, Kuzmina N, Bukreyev A, Grys TE, Wu L, Mills JR, McAulay K, Gonzalez-Moa M, Seit-Nebi A, Svarovsky S.
Lake DF, et al. Among authors: roeder aj.
J Clin Virol. 2021 Dec;145:105024. doi: 10.1016/j.jcv.2021.105024. Epub 2021 Nov 4.
J Clin Virol. 2021.
PMID: 34781240
Free PMC article.
Item in Clipboard
Letter to the editor RE: Fulford et al., 2021 'A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2'.
Lake DF, Roeder AJ, Seit-Nebi A, Gonzalez-Moa MJ, Svarovsky S.
Lake DF, et al. Among authors: roeder aj.
EBioMedicine. 2022 Mar;77:103898. doi: 10.1016/j.ebiom.2022.103898. Epub 2022 Feb 24.
EBioMedicine. 2022.
PMID: 35220041
Free PMC article.
No abstract available.
Item in Clipboard
Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501YMA30 Strain of SARS-CoV-2.
Kibler KV, Szczerba M, Lake D, Roeder AJ, Rahman M, Hogue BG, Roy Wong LY, Perlman S, Li Y, Jacobs BL.
Kibler KV, et al. Among authors: roeder aj.
Vaccines (Basel). 2022 Jul 23;10(8):1172. doi: 10.3390/vaccines10081172.
Vaccines (Basel). 2022.
PMID: 35893821
Free PMC article.
Item in Clipboard
Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501Y MA30 strain of SARS-CoV-2.
Kibler KV, Szczerba M, Lake D, Roeder AJ, Rahman M, Hogue BG, Roy Wong LY, Perlman S, Li Y, Jacobs BL.
Kibler KV, et al. Among authors: roeder aj.
bioRxiv. 2021 Dec 8:2021.12.06.471483. doi: 10.1101/2021.12.06.471483. Preprint.
bioRxiv. 2021.
PMID: 34909775
Free PMC article.
Updated.
Item in Clipboard
Cite
Cite